James Cassidy

James Cassidy

Plus aucun poste en cours
67 ans
Health Technology
Consumer Services

Profil

James Cassidy formerly worked at Springworks Therapeutics, Inc., as Chief Medical Officer from 2021 to 2025, Hoffmann-La Roche, Inc., as Global Head-Translational Research for Oncology, the University of Glasgow, as Professor-Oncology from 2002 to 2011, Celgene LLC, as Vice President-Translational Development from 2016 to 2020, Bristol Myers Squibb Co., as Vice President-Oncology from 2013 to 2016, and Regeneron Pharmaceuticals, Inc., as VP-Oncology Strategic Program Direction from 2020 to 2021.
Dr. Cassidy received his doctorate degree in 1981 from the University of Glasgow.

Anciens postes connus de James Cassidy

SociétésPosteFin
SPRINGWORKS THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 01/07/2025
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 01/08/2021
Celgene LLC
Corporate Officer/Principal 01/01/2020
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/10/2016
Corporate Officer/Principal 01/01/2011
Voir l'expérience en détail de James Cassidy

Formation de James Cassidy

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Health Technology

Health Technology

Consumer Services

Celgene LLC

Health Technology

  1. Bourse
  2. Insiders
  3. James Cassidy
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇